23 June 2012
Randomized Clinical Trials
Randomized clinical trials play a central role in the advancement of knowledge about new and existing interventions for the prevention and treatment of disease, and the interpretation of the results of most clinical trials requires a careful balance of the apparent results and the limitations of the underlying study. With an aim of improving one's ability to critically evaluate published results about clinical trials, this course will provide an introduction to the methods used in the design, interim monitoring, and analysis of clinical trials, including the impact of patient exclusions and other causes of incomplete data. The course will emphasize concepts and principles, and the main focus will be on randomized Phase III (comparative) trials. The morning sessions will consist of lectures, while the afternoon sessions will discuss case studies from recently published trials, as well as practical experience in study design.
D. Harrington (Harvard University)
Physicians, clinicians and public health professionals from public and private institutions who are looking for systematic training in the principles of epidemiology and biostatistics, or epidemiology applied to health care planning and evaluation.
Students in biostatistics and epidemiology, and researchers both from public and private institutions who wish to increase their familiarity with quantitative methods or to deepen their knowledge of a specific area of interest.
Provide an introduction to the methods used in the design, interim monitoring, and analysis of clinical trials, including the impact of patient exclusions and other causes of incomplete data.
EUR 1150: For Students. Registration before 31 March 2012.
After 31 March 2012 €1,350.
EUR 1250: Registration before 31 March 2012.
After 31 March 2012 €1,450.
A limited number of Scholarships are available.
Scholarships cover the cost of tuition, for at most one week. Only registered students may apply. The request to be considered for a scholarship should be communicated no later than March 1, 2012.